KLOW COA

KLOW — Certificate of Analysis

The information below summarizes analytical documentation associated with the identified sample or batch of KLOW.

ANALYTICAL INFORMATION

• Compound: KLOW — GHK-Cu + TB-500 + BPC-157 + KPV
• Lot / Batch: 2026-05
• Purity: 99.91%
• Identity: Confirmed — GHK-Cu + TB-500 + BPC-157 + KPV
• Testing Method: Blend Purity & Quantitation (HPLC); HPLC identity confirmation
• Laboratory: ILS Laboratories
• COA #: COA-2026-PBUVRS
• Analysis Date: June 2, 2026
• Fentanyl Screen: Not Detected
• Endotoxin: 0.059 EU/mL

BATCH-SPECIFIC DOCUMENTATION

Analytical results apply only to the sample or batch identified in the corresponding laboratory report. Results for one sample or batch should not be interpreted as results for a different sample or batch.

RESEARCH USE ONLY

This information is provided for laboratory research documentation purposes only. Testing documentation does not establish FDA approval, safety, efficacy, or suitability for human, veterinary, diagnostic, or therapeutic use.